Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Jun 10, 2015; 7(6): 643-651
Published online Jun 10, 2015. doi: 10.4253/wjge.v7.i6.643
Published online Jun 10, 2015. doi: 10.4253/wjge.v7.i6.643
Ref. | Treatment | Indication | Patients (n) | Conclusion | |
CD | Niv et al[2] | Yes | SB mucosa evaluation of known CD patients | 19 | Musocal findings are independent from clinical and laboratory parameters |
CD | Hall et al[1] | Yes | SB mucosal healing and deep remission rates assessment on 12 wk of treatment of known symptomatic CD patients | 43 | Symptomatic and biochemical response to treatment is not mirrored by mucosal healing |
CD | Hall et al[33] | Yes | SB mucosal healing and deep remission rates assessment on 52 wk of treatment of known symptomatic CD patients | 43 | Symptomatic and biochemical response to treatment appears to be mirrored by endoscopic remission in 42% of individuals |
CD | Efthymiou et al[3] | Yes | SB mucosal healing assessment of known symptomatic CD patients | 40 | Clinical response does not correlate closely with mucosal healing in patients with CD of the small bowel |
CD | Tsibouris et al[32] | Yes | Assessment of detection rate of small bowel ulcerative lesions and completion rate in CD patients in acute phase and remission | 102 | SB aphthous ulcers are present a month after entering clinical remission |
- Citation: Mitselos IV, Christodoulou DK, Katsanos KH, Tsianos EV. Role of wireless capsule endoscopy in the follow-up of inflammatory bowel disease. World J Gastrointest Endosc 2015; 7(6): 643-651
- URL: https://www.wjgnet.com/1948-5190/full/v7/i6/643.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i6.643